The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein

Coronaviridae is recognized as one of the most rapidly evolving virus family as a consequence of the high genomic nucleotide substitution rates and recombination. The family comprises a large number of enveloped, positive-sense single-stranded RNA viruses, causing an array of diseases of varying sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Piacentini, Sara, Riccio, Anna, Santopolo, Silvia, Pauciullo, Silvia, La Frazia, Simone, Rossi, Antonio, Rossignol, Jean-Francois, Santoro, M. Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497118/
https://www.ncbi.nlm.nih.gov/pubmed/37705731
http://dx.doi.org/10.3389/fmicb.2023.1206951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497118/
https://www.ncbi.nlm.nih.gov/pubmed/37705731
http://dx.doi.org/10.3389/fmicb.2023.1206951

Ejemplares similares